A new case of prostatic carcinosarcoma was reported, highlighting its rarity and aggressive nature.
The patient presented with a large pelvic mass and pulmonary metastasis, undergoing multiple treatments including cystoprostatectomy and chemotherapy.
Despite treatment, the cancer progressed rapidly, leading to an 18-month survival, demonstrating that this type of prostate cancer is resistant to standard therapies.